Try our free ADHD Screening Tool Next available appointment: typically 6 to 8 weeks Book now →
Library guide Co-Occurring Conditions For adults with adhd, anxiety, or both

ADHD and Anxiety: Why They Travel Together

Why anxiety co-occurs so often with ADHD, what the prevalence data shows, how to tell apart cause and effect, and what UK treatment looks like in practice.

Reviewed 25 May 2025 Next review May 2026 ~1,500 words · 8 min read Clinically reviewed

Anxiety and ADHD co-occur far above chance. Most adults with ADHD will at some point in their lives meet criteria for an anxiety disorder, and a substantial proportion of people who present with anxiety as their primary concern turn out to have undiagnosed ADHD underneath. This article covers the prevalence picture, the reasons why these two conditions travel together, the practical difficulty of telling apart cause and effect, and what UK treatment looks like when both are present.

How often anxiety co-occurs with ADHD

The most cited single-source figure comes from the US National Comorbidity Survey Replication, in which around 47 percent of adults meeting ADHD criteria also met criteria for any anxiety disorder in the past year, compared with around 20 percent of adults without ADHD [5]. UK and European cohort studies report similar rates, with generalised anxiety disorder, social anxiety disorder and panic disorder all over-represented in ADHD samples [6].

The picture in children and adolescents with ADHD is similar in shape but slightly different in proportion. Roughly a quarter to a third of children with ADHD will also meet criteria for an anxiety disorder at some point in childhood or adolescence [4]. Specific phobia, separation anxiety, social anxiety and generalised anxiety are all over-represented.

These are not coincidences. They are evidence of two conditions that interact at multiple levels.

Why the two travel together

Several mechanisms contribute, and most patients with both will have more than one of them at play [4, 6]:

Shared underlying biology

Both ADHD and anxiety involve disrupted regulation of the prefrontal cortex and its connections to subcortical emotion centres. Both involve noradrenaline signalling. The genetic studies show some overlap in the risk factors for the two conditions, though the conditions are distinct and not simply the same disorder.

Anxiety as a downstream consequence of ADHD

Living with undiagnosed or unmanaged ADHD generates a steady supply of reasons to be anxious. Missed deadlines, forgotten commitments, repeated experiences of being judged for behaviour the person cannot easily change, sustained underperformance relative to ability, financial chaos from impulsive spending, social difficulties from interrupting or mis-attuning. Many adults with ADHD who present primarily with anxiety symptoms are anxious because their lives are difficult in concrete, ADHD-related ways. The anxiety is the result, not the cause.

Anxiety as a coping mechanism

Hypervigilance and pre-emptive worry can compensate for ADHD-related forgetfulness and disorganisation in the short term. Many adults describe relying on anxiety to "make them" remember things, prepare for events, or stay on task. The cost is sustained nervous-system arousal and exhaustion, but the mechanism is real and is part of why anxiety often persists even after ADHD treatment begins.

Misdiagnosis of one as the other

ADHD inattention, difficulty initiating tasks, and emotional dysregulation can be mistaken for anxiety, particularly in women and girls who do not present with overt hyperactivity. Many adults with ADHD have been treated for anxiety for years before the underlying ADHD is recognised. Treating only the anxiety does not address the underlying ADHD-driven difficulty, which is part of why the anxiety treatment often produces a more limited response than expected.

Genuine independent co-occurrence

Sometimes the two are simply two separate conditions in the same person, each running its own course. The clinical work is then to treat both, in parallel, with the right tools for each.

The practical difficulty of telling them apart

In clinical practice, the question "is this anxiety or ADHD?" often has the answer "both, and the proportions matter". A few patterns help [3, 4]:

  • Anxiety usually has a strong cognitive worry component. Repeated thoughts about future or past events, rumination, catastrophising. ADHD inattention is less about worry and more about distractibility.
  • ADHD inattention is context-dependent. Difficulty with boring tasks, but often near-normal focus on engaging ones. Anxiety-driven inattention tends to be more uniform across contexts and is often worse when the threat or worry is most salient.
  • The childhood pattern matters. ADHD criteria require onset before age twelve. A pattern that genuinely started in adulthood, with no childhood evidence, is unlikely to be ADHD.
  • The response to treatment is informative. Anxiety treatment that produces good response on standard endpoints but leaves persistent attention, task-initiation and emotional-regulation difficulties points towards underlying ADHD. ADHD medication that improves focus but worsens anxiety points towards either a stimulant choice that does not suit, or a separate anxiety condition that needs its own treatment.

How treatment works when both are present

NICE NG87 acknowledges co-occurring anxiety explicitly and recommends that both conditions are addressed [2]. The practical sequence varies by which is the more impairing and how stable each is. Common patterns:

Treat the most impairing condition first

If anxiety is severe enough to disable daily function, anxiety treatment usually starts first. If ADHD difficulties dominate and the anxiety is more proportionate to the daily ADHD-related stress, ADHD treatment may produce useful improvement in both.

Choose ADHD medication with anxiety in mind

Some patients find stimulants amplify anxiety symptoms; others find stimulants improve them by improving the prefrontal regulation that handles worry. Lisdexamfetamine and methylphenidate behave differently in this regard for different individuals. Where stimulants worsen anxiety despite formulation and timing adjustment, atomoxetine is an alternative that often improves both ADHD and co-occurring anxiety in the same patient [4]. The detail is part of the ADHD medication and prescribing with NeuroFX pathway.

NICE CG113 sets out the approach for generalised anxiety disorder and panic disorder in adults: cognitive behavioural therapy (CBT) as a first-line psychological treatment, with SSRIs or SNRIs as the first-line pharmacological options where medication is appropriate [3]. The presence of ADHD does not change these recommendations; it informs how they are sequenced and what to watch for.

Use psychological support that recognises both

CBT for anxiety is more effective when the ADHD-related difficulties (task initiation, attention to therapy homework, follow-through between sessions) are taken into account. ADHD-informed therapy is increasingly available and often suits this picture better than standard CBT delivered without the ADHD context.

Consider the broader picture

Sleep, alcohol, caffeine, physical exercise, and structural changes to demands all affect both conditions. ADHD diagnosis is more than medication makes the case that treatment is a package; that is particularly true where anxiety is also present.

When the anxiety is the late-diagnosis pattern

A common adult presentation is anxiety that has been treated for years without full resolution, sometimes with multiple medication changes and rounds of therapy, and that turns out to sit on undiagnosed ADHD. The pattern looks like this: anxiety treatment helps but does not finish the job; concentration, task initiation and emotional regulation difficulties persist; life events that should be calming (a new job that fits, a long-anticipated holiday) still feel hard. A private adult ADHD assessment, or an NHS or Right to Choose assessment, is a sensible next step in this pattern.

What this means in practice

  • Anxiety and ADHD co-occur far above chance. Around 47 percent of adults with ADHD also meet criteria for an anxiety disorder in the past year.
  • Multiple mechanisms contribute: shared biology, anxiety as a downstream consequence of ADHD, anxiety as a coping mechanism, misdiagnosis of one as the other, and genuine independent co-occurrence.
  • Disentangling them is a clinical conversation. The cognitive worry component, the context-dependence of inattention, the childhood pattern, and the response to treatment all help.
  • Treatment usually addresses both. ADHD medication choice can be informed by the anxiety picture (atomoxetine is sometimes preferred where stimulants worsen anxiety).
  • Anxiety treatment that helps but does not finish the job is one of the most common adult presentations of underlying undiagnosed ADHD.

When to speak to a professional

Speak to your GP if anxiety has been treated without full resolution and ADHD-type difficulties have been present since childhood. NHS routes for ADHD assessment and anxiety treatment exist; Right to Choose in England applies to ADHD. NeuroFX offers private ADHD assessment for adults and children aged 6 and upwards, including consideration of co-occurring anxiety from the start. Seek urgent help via 111, 999 or A&E for any acute mental health crisis.

Sources

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022.
  2. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87
  3. NICE. Generalised anxiety disorder and panic disorder in adults: management. CG113. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/cg113
  4. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
  5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry. 2006;163(4):716-723.
  6. Katzman MA, Bilkey TS, Chokka PR, et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. 2017;17:302.

References & evidence

Last reviewed 25 May 2025. Next scheduled review: May 2026. Reviewed by Tina Fox, Specialist Neurodevelopmental Practitioner & Independent Prescriber.

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
  2. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. https://www.nice.org.uk/guidance/ng87
  3. NICE. Generalised anxiety disorder and panic disorder in adults: management. CG113. https://www.nice.org.uk/guidance/cg113
  4. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818.
  5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723.
  6. Katzman MA, Bilkey TS, Chokka PR, et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. 2017;17:302.
Tina Fox
Reviewed by

Tina Fox

Specialist Neurodevelopmental Practitioner & Independent Prescriber

Tina is Clinical Lead at NeuroFX, with 15 years of specialist mental health nursing experience and as an advanced specialist paediatric sleep practitioner. She personally leads NeuroFX assessments and prescribing, and clinically reviews the guidance published here against current NICE standards.

Read Tina's full profile →
WhatsApp Call us Book